| TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from hormone therapy pharmaceutical products to patient-controlled, long-acting contraceptive. Co.'s Hormone Therapy Drugs: IMVEXXY for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy, due to menopause; BIJUVA for the treatment of moderate-to-severe vasomotor symptoms, due to menopause in women with a uterus; and ANNOVERA, a one-year ring-shaped contraceptive vaginal system. We show 42 historical shares outstanding datapoints in our TXMD shares outstanding history coverage, used to compute TXMD market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TXMD market cap history over the course of time is important for investors
interested in comparing TXMD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TXMD versus a peer is one thing; comparing
TXMD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TXMD can fluctuate over the course of history.
With this page we aim to empower investors researching TXMD by allowing them to research the TXMD market cap history.